Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma for high-risk COVID-19 patients
NCT04836260Phase 3Unknown
- Start
- Apr 2021
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
A Phase 3 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04836260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04836260.